| Name | 6-hydroxy-5-nitro-2-(trifluoromethyl)-2,3-dihydro-1H-pyrimidin-4-one |
|---|---|
| Synonyms |
5-nitro-2-trifluoromethyl-1H-pyrimidine-4,6-dione
5-Nitro-4,6-dihydroxy-2-trifluormethyl-pyrimidin 5-Nitro-2-(trifluoromethyl)-1,2-dihydropyrimidine-4,6-diol 5-nitro-2-(trifluoromethyl)pyrimidine-4,6-diol |
| Density | 1.905g/cm3 |
|---|---|
| Boiling Point | 220.7ºC at 760 mmHg |
| Molecular Formula | C5H4F3N3O4 |
| Molecular Weight | 227.09800 |
| Flash Point | 87.3ºC |
| Exact Mass | 227.01500 |
| PSA | 110.67000 |
| LogP | 0.72590 |
| Index of Refraction | 1.551 |
| HS Code | 2933599090 |
|---|
|
~%
652-62-0 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/136442 A1, 2006 ; Location in patent: Page/Page column 26-27 ; WO 2006/136442 A1 |
| Precursor 1 | |
|---|---|
| DownStream 3 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |